Greg Johnson has been making music and touring for nearly 40 years, and this year marks the 30th anniversary of his third album ‘Vine Street Stories’. The album is home to many of Johnson’s ...

A New Zealand man has been charged with one count of importing a commercial quantity of a border-controlled drug. Photo / Australian Border Force A 21-year-old New Zealand man will appear in a ...

It's thought consistency is key as the Government moves to ban all under 18s from buying all Lotto products. Currently, only Instant Kiwi products have an age limit. Internal Affairs Minister ...

Neuro research in New Zealand has received a significant boost in the latest Neurological Foundation grant round. The Foundation – the biggest non-government funder of neurological research in ...

Kiwi sex therapist Sofie Louise explains how to transform your sex life this year, with resolutions for more intimacy and pleasure. It’s that time of year to resolve that 2025 is when you’ll ...

Gifting allows recipients to access the article for free. The hair-care company Johnson Products is justly celebrated as the first Black-owned company to go public, leading to a listing on the ...

(To receive weekly emails of conversations with the world’s top CEOs and decisionmakers, click here.) It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

Johnson Outdoors Q1 EPS of $(1.49) misses consensus estimate. Johnson Outdoors remains confident in its ability to create long-term value and pay dividends to shareholders. Next: Access Our New ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...